Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23402365 | 0.91 | CNR1 (0.36) | CNR1CNR2 | |
| SCHEMBL23399257 | 0.87 | KDM4E (0.31) | — | |
| SCHEMBL23398736 | 0.84 | KDM4E (0.31) | — | |
| SCHEMBL23402574 | 0.83 | CNR1 (0.35) | CNR1CNR2 | |
| SCHEMBL23399962 | 0.82 | CNR1 (0.32) | CNR1CNR2 | |
| SCHEMBL23401321 | 0.81 | CNR1 (0.36) | CNR1CNR2 | |
| SCHEMBL23402099 | 0.80 | KDM4E (0.33) | — | |
| SCHEMBL23400442 | 0.79 | KDM4E (0.35) | — | |
| SCHEMBL23403579 | 0.79 | GRIA4 (0.34) | — | |
| SCHEMBL23403660 | 0.78 | GRIA4 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2024-06-27 | — | — | US | disclosed |
| EP-4326783-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2024-02-28 | — | — | EP | disclosed |
| CN-117222675-A | polymerization inhibitor | 巴斯夫欧洲公司 | 2023-12-12 | — | — | CN | disclosed |
| WO-2022223336-A1 | POLYMERIZATION INHIBITORS | BASF SE (DE) | 2022-10-27 | — | — | WO | disclosed |
| EP-3828159-A1 | STORAGE AND TRANSPORT STABILIZERS FOR POLYMERIZABLE COMPOUNDS | BASF SE (DE) | 2021-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208911-A1 | POLYMERIZATION INHIBITORS | CDK5, CABLES1, DPYD | CNR1 4041/4885CNR2 4119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.